AMYLIN PHARMACEUTICALS INC: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2011)
- $650.7M
- Net Income/Loss (FY2011)
- -$543.4M
- Total Assets (FY2011)
- $1.9B
- Total Equity (FY2011)
- -$138.7M
- Cash Flows from Operating Activities (FY2011)
- $88.3M
Source: AMYLIN PHARMACEUTICALS INC 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
